
Upfront Disease Modification: How Winrevair's HYPERION Label Update Rewrites Pulmonary Vascular Care
Dr. Dereck Mush, MD, MBAChairman and Chief Executive Officer, Merck
Robert M. Davis, also known as Rob Davis, leads Merck. Before joining the company, he was president of Baxter's Medical Products business and earlier served as Baxter's CFO and treasurer.
How Robert M. Davis got here, step by step.
2014
Appointed Chief Financial Officer.
April 2021
Became president of Merck.
July 2021
Became CEO.
December 2022
Became chairman.

Dr. Dereck Mush, MD, MBAMentions Merck

Dr. Dereck Mush, MD, MBAMentions Merck

Dr. Dereck Mush, MD, MBAMentions Merck

Newsletter
The WINREVAIR briefing

Newsletter
The Variational AI collaboration briefing
Newsletter
The Merck and Moderna vaccine briefing
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: